| Company | Timeline | Status | |
| Sandymount Therapeutics Ltd Director • Chief Executive Officer | 9 Feb 2024←1 Year 8 Months→Current | Active | |
| Kleidox Therapeutics Ltd Director • Chief Executive Officer | 9 Feb 2024←1 Year 8 Months→Current | Active | |
| Dark Blue Therapeutics Ltd Director • Chief Executive Officer | 8 Aug 2022←3 Years→Current | Active | |
| Mereo Biopharma 4 Limited Director • Chief Portfolio Management And Pipeline Strategy E | 24 Oct 2017←4 Years→29 Jul 2022 | Active | |
| Phase4 Partners Limited Director • Venture Capitalist | 25 Sep 2015←4 Years→5 Dec 2019 | Dissolved | |
| Mereo Biopharma 2 Limited Director • Chief Portfolio Management And Pipeline Strategy E | 30 Jun 2015←7 Years→29 Jul 2022 | Active | |
| Mereo Biopharma 3 Limited Director • Chief Portfolio Management And Pipeline Strategy E | 30 Jun 2015←7 Years→29 Jul 2022 | Active | |
| Mereo Biopharma 1 Limited Director • Chief Portfolio Management And Pipeline Strategy E | 30 Jun 2015←7 Years→29 Jul 2022 | Active | |
